Global Neurologic Disorders Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 75 pages | ID: G47A187E9E8EN
LP Information

Abstracts

According to this study, the global Neurologic Disorders Therapeutics market size will reach US$ million by 2031.

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Neurologic Disorders Therapeutics Industry Forecast” looks at past sales and reviews total world Neurologic Disorders Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurologic Disorders Therapeutics sales for 2025 through 2031. With Neurologic Disorders Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurologic Disorders Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Neurologic Disorders Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurologic Disorders Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurologic Disorders Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurologic Disorders Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurologic Disorders Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurologic Disorders Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Central Nervous System (CNS)
• Peripheral Nervous System (PNS)

Segmentation by Application:

• Paralysis
• Muscle Weakness
• Poor Coordination
• Loss of Sensation
• Seizures
• Confusion
• Pain and Altered Levels of Consciousness

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Biogen Inc.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• Novartis AG
• Pfizer Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neurologic Disorders Therapeutics Market Size (2020-2031)
  2.1.2 Neurologic Disorders Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Neurologic Disorders Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Neurologic Disorders Therapeutics Segment by Type
  2.2.1 Central Nervous System (CNS)
  2.2.2 Peripheral Nervous System (PNS)
2.3 Neurologic Disorders Therapeutics Market Size by Type
  2.3.1 Neurologic Disorders Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Neurologic Disorders Therapeutics Segment by Application
  2.4.1 Paralysis
  2.4.2 Muscle Weakness
  2.4.3 Poor Coordination
  2.4.4 Loss of Sensation
  2.4.5 Seizures
  2.4.6 Confusion
  2.4.7 Pain and Altered Levels of Consciousness
2.5 Neurologic Disorders Therapeutics Market Size by Application
  2.5.1 Neurologic Disorders Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2020-2025)

3 NEUROLOGIC DISORDERS THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Neurologic Disorders Therapeutics Market Size Market Share by Player
  3.1.1 Global Neurologic Disorders Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Neurologic Disorders Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEUROLOGIC DISORDERS THERAPEUTICS BY REGION

4.1 Neurologic Disorders Therapeutics Market Size by Region (2020-2025)
4.2 Global Neurologic Disorders Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurologic Disorders Therapeutics Market Size Growth (2020-2025)
4.4 APAC Neurologic Disorders Therapeutics Market Size Growth (2020-2025)
4.5 Europe Neurologic Disorders Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Neurologic Disorders Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Neurologic Disorders Therapeutics Market Size by Country (2020-2025)
5.2 Americas Neurologic Disorders Therapeutics Market Size by Type (2020-2025)
5.3 Americas Neurologic Disorders Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neurologic Disorders Therapeutics Market Size by Region (2020-2025)
6.2 APAC Neurologic Disorders Therapeutics Market Size by Type (2020-2025)
6.3 APAC Neurologic Disorders Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Neurologic Disorders Therapeutics Market Size by Country (2020-2025)
7.2 Europe Neurologic Disorders Therapeutics Market Size by Type (2020-2025)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neurologic Disorders Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NEUROLOGIC DISORDERS THERAPEUTICS MARKET FORECAST

10.1 Global Neurologic Disorders Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Neurologic Disorders Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Neurologic Disorders Therapeutics Forecast
  10.1.3 APAC Neurologic Disorders Therapeutics Forecast
  10.1.4 Europe Neurologic Disorders Therapeutics Forecast
  10.1.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast
10.2 Americas Neurologic Disorders Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Neurologic Disorders Therapeutics Forecast
  10.2.2 Canada Market Neurologic Disorders Therapeutics Forecast
  10.2.3 Mexico Market Neurologic Disorders Therapeutics Forecast
  10.2.4 Brazil Market Neurologic Disorders Therapeutics Forecast
10.3 APAC Neurologic Disorders Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Neurologic Disorders Therapeutics Market Forecast
  10.3.2 Japan Market Neurologic Disorders Therapeutics Forecast
  10.3.3 Korea Market Neurologic Disorders Therapeutics Forecast
  10.3.4 Southeast Asia Market Neurologic Disorders Therapeutics Forecast
  10.3.5 India Market Neurologic Disorders Therapeutics Forecast
  10.3.6 Australia Market Neurologic Disorders Therapeutics Forecast
10.4 Europe Neurologic Disorders Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Neurologic Disorders Therapeutics Forecast
  10.4.2 France Market Neurologic Disorders Therapeutics Forecast
  10.4.3 UK Market Neurologic Disorders Therapeutics Forecast
  10.4.4 Italy Market Neurologic Disorders Therapeutics Forecast
  10.4.5 Russia Market Neurologic Disorders Therapeutics Forecast
10.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Neurologic Disorders Therapeutics Forecast
  10.5.2 South Africa Market Neurologic Disorders Therapeutics Forecast
  10.5.3 Israel Market Neurologic Disorders Therapeutics Forecast
  10.5.4 Turkey Market Neurologic Disorders Therapeutics Forecast
10.6 Global Neurologic Disorders Therapeutics Forecast by Type (2026-2031)
10.7 Global Neurologic Disorders Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Neurologic Disorders Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Biogen Inc.
  11.1.1 Biogen Inc. Company Information
  11.1.2 Biogen Inc. Neurologic Disorders Therapeutics Product Offered
  11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Biogen Inc. Main Business Overview
  11.1.5 Biogen Inc. Latest Developments
11.2 F. Hoffmann-La Roche Ltd.
  11.2.1 F. Hoffmann-La Roche Ltd. Company Information
  11.2.2 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
  11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.3 Johnson & Johnson Services Inc.
  11.3.1 Johnson & Johnson Services Inc. Company Information
  11.3.2 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
  11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Johnson & Johnson Services Inc. Main Business Overview
  11.3.5 Johnson & Johnson Services Inc. Latest Developments
11.4 Novartis AG
  11.4.1 Novartis AG Company Information
  11.4.2 Novartis AG Neurologic Disorders Therapeutics Product Offered
  11.4.3 Novartis AG Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis AG Main Business Overview
  11.4.5 Novartis AG Latest Developments
11.5 Pfizer Inc.
  11.5.1 Pfizer Inc. Company Information
  11.5.2 Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
  11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer Inc. Main Business Overview
  11.5.5 Pfizer Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neurologic Disorders Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Neurologic Disorders Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Central Nervous System (CNS)
Table 4. Major Players of Peripheral Nervous System (PNS)
Table 5. Neurologic Disorders Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Neurologic Disorders Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Neurologic Disorders Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Neurologic Disorders Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Neurologic Disorders Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Neurologic Disorders Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Neurologic Disorders Therapeutics Key Players Head office and Products Offered
Table 14. Neurologic Disorders Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neurologic Disorders Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Neurologic Disorders Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Neurologic Disorders Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Neurologic Disorders Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Neurologic Disorders Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Neurologic Disorders Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Neurologic Disorders Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Neurologic Disorders Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Neurologic Disorders Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Neurologic Disorders Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Neurologic Disorders Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Neurologic Disorders Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Neurologic Disorders Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Neurologic Disorders Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Neurologic Disorders Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Neurologic Disorders Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Neurologic Disorders Therapeutics
Table 39. Key Market Challenges & Risks of Neurologic Disorders Therapeutics
Table 40. Key Industry Trends of Neurologic Disorders Therapeutics
Table 41. Global Neurologic Disorders Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Neurologic Disorders Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Neurologic Disorders Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Biogen Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 46. Biogen Inc. Neurologic Disorders Therapeutics Product Offered
Table 47. Biogen Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Biogen Inc. Main Business
Table 49. Biogen Inc. Latest Developments
Table 50. F. Hoffmann-La Roche Ltd. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 51. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
Table 52. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. F. Hoffmann-La Roche Ltd. Main Business
Table 54. F. Hoffmann-La Roche Ltd. Latest Developments
Table 55. Johnson & Johnson Services Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 56. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
Table 57. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Johnson & Johnson Services Inc. Main Business
Table 59. Johnson & Johnson Services Inc. Latest Developments
Table 60. Novartis AG Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 61. Novartis AG Neurologic Disorders Therapeutics Product Offered
Table 62. Novartis AG Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Novartis AG Main Business
Table 64. Novartis AG Latest Developments
Table 65. Pfizer Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 66. Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
Table 67. Pfizer Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Pfizer Inc. Main Business
Table 69. Pfizer Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Neurologic Disorders Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurologic Disorders Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Neurologic Disorders Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Neurologic Disorders Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Neurologic Disorders Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Neurologic Disorders Therapeutics Market Size Market Share by Type in 2024
Figure 10. Neurologic Disorders Therapeutics in Paralysis
Figure 11. Global Neurologic Disorders Therapeutics Market: Paralysis (2020-2025) & ($ millions)
Figure 12. Neurologic Disorders Therapeutics in Muscle Weakness
Figure 13. Global Neurologic Disorders Therapeutics Market: Muscle Weakness (2020-2025) & ($ millions)
Figure 14. Neurologic Disorders Therapeutics in Poor Coordination
Figure 15. Global Neurologic Disorders Therapeutics Market: Poor Coordination (2020-2025) & ($ millions)
Figure 16. Neurologic Disorders Therapeutics in Loss of Sensation
Figure 17. Global Neurologic Disorders Therapeutics Market: Loss of Sensation (2020-2025) & ($ millions)
Figure 18. Neurologic Disorders Therapeutics in Seizures
Figure 19. Global Neurologic Disorders Therapeutics Market: Seizures (2020-2025) & ($ millions)
Figure 20. Neurologic Disorders Therapeutics in Confusion
Figure 21. Global Neurologic Disorders Therapeutics Market: Confusion (2020-2025) & ($ millions)
Figure 22. Neurologic Disorders Therapeutics in Pain and Altered Levels of Consciousness
Figure 23. Global Neurologic Disorders Therapeutics Market: Pain and Altered Levels of Consciousness (2020-2025) & ($ millions)
Figure 24. Global Neurologic Disorders Therapeutics Market Size Market Share by Application in 2024
Figure 25. Global Neurologic Disorders Therapeutics Revenue Market Share by Player in 2024
Figure 26. Global Neurologic Disorders Therapeutics Market Size Market Share by Region (2020-2025)
Figure 27. Americas Neurologic Disorders Therapeutics Market Size 2020-2025 ($ millions)
Figure 28. APAC Neurologic Disorders Therapeutics Market Size 2020-2025 ($ millions)
Figure 29. Europe Neurologic Disorders Therapeutics Market Size 2020-2025 ($ millions)
Figure 30. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2020-2025 ($ millions)
Figure 31. Americas Neurologic Disorders Therapeutics Value Market Share by Country in 2024
Figure 32. United States Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. Canada Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Mexico Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. Brazil Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region in 2024
Figure 37. APAC Neurologic Disorders Therapeutics Market Size Market Share by Type (2020-2025)
Figure 38. APAC Neurologic Disorders Therapeutics Market Size Market Share by Application (2020-2025)
Figure 39. China Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Japan Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. South Korea Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. Southeast Asia Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. India Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Australia Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country in 2024
Figure 46. Europe Neurologic Disorders Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Europe Neurologic Disorders Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Germany Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. France Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. UK Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Italy Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Russia Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Region (2020-2025)
Figure 54. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Type (2020-2025)
Figure 55. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Application (2020-2025)
Figure 56. Egypt Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. South Africa Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 58. Israel Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 59. Turkey Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 60. GCC Countries Neurologic Disorders Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 61. Americas Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. APAC Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Europe Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. United States Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Canada Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Mexico Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Brazil Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. China Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Japan Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Korea Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Southeast Asia Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. India Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Australia Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Germany Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. France Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. UK Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Italy Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 79. Russia Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 80. Egypt Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 81. South Africa Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 82. Israel Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 83. Turkey Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)
Figure 84. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 85. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 86. GCC Countries Neurologic Disorders Therapeutics Market Size 2026-2031 ($ millions)